What is the translation of " WERE COMPARABLE " in Croatian?

[w3ːr 'kɒmpərəbl]
Adjective
[w3ːr 'kɒmpərəbl]

Examples of using Were comparable in English and their translations into Croatian

{-}
  • Colloquial category close
  • Ecclesiastic category close
  • Computer category close
But fatalities were comparable to seasonal flu.
Ali smrtnost se mogla usporediti sa sezonskom gripom.
The main thing that all the parts were comparable.
Glavna stvar da su svi dijelovi bili usporedivi.
The results were comparable with those of the reported methods.
Rezultati predložene metode usporedivi su s rezultatima poznatih metoda.
Major bleeding rates with this dose were comparable to warfarin.
Stopa velikog krvarenja uz ovu dozu bila je usporediva s varfarinom.
The results were comparable with those of the reported methods.
Rezultati predloÅ3⁄4ene metode usporedivi su s rezultatima poznatih metoda.
The safety profiles of the administered vaccines were comparable see section 4.8.
Primijenjena cjepiva imala su usporediv sigurnosni profil vidjeti dio 4.8.
The outcomes were comparable with those found in the NINDS t-PA trial.
Rezultati funkcionalnog ishoda su uspoređeni sa ishodom navedenim u studiji NINDS t-PA.
The safety profiles of the recommended dose andhalf of the recommended dose were comparable.
Sigurnosni profil preporučene doze ipolovine preporučene doze bili su usporedivi.
TSAT and total serum iron profiles were comparable between Day 1 and Day 8.
Profili TSAT-a i ukupnog željeza u serumu bili su usporedivi između 1. i 8. dana.
When given intravenously the elimination half-lifeof insulin glargine and human insulin were comparable.
Poluvijek eliminacije inzulina glargina iljudskog inzulina nakon intravenske primjene bio je usporediv.
Football broadcast in"VKontakte" were comparable in terms of audience with television.
Nogomet emitirati u„Vkontakte” su usporedivi u smislu publike s televizije.
The mean serum interferon concentrations following subcutaneous andintramuscular injections were comparable.
Srednje koncentracije interferona u serumu nakon supkutane iintramuskularne injekcije bile su slične.
PK parameters for rituximab were comparable over the two treatment courses.
Farmakokinetički parametri za rituksimab bili su slični tijekom dva ciklusa liječenja.
When given intravenously the elimination half-life of insulin glargine andhuman insulin were comparable.
Kod intravenske je primjene poluvrijeme eliminacije inzulina glargina iljudskog inzulina bilo usporedivo.
The ritonavir exposures were comparable between Asians and non-Asians.
Izloženost ritonaviru je bila usporediva između Azijata i onih koji nisu Azijati.
The baseline characteristics andduration of fondaparinux treatment were comparable in both UFH groups.
Ishodišne karakteristike itrajanje liječenja fondaparinuksom su bile usporedive za obje UFH skupine.
Creatinine increases were comparable by various background regimens.
Povećanja vrijednosti kreatinina bila su usporediva kod primjene različitih osnovnih režima liječenja.
In a population pharmacokinetic analysis of the ENGAGE AF-TIMI 48 study, peak and total exposure in Asian patients andnon-Asian patients were comparable.
U analizi populacijske farmakokinetike u ispitivanju ENGAGE AF-TIMI 48, vršna i ukupna izloženost u azijatskih bolesnika ine-azijatskih bolesnika bile su usporedive.
After the second dose immune responses were comparable to those after the first dose.
Nakon druge doze imunološki odgovori bili su usporedivi s onima nakon prve doze.
After the booster dose a lower percentage of subjects with OPA titres 8 was observed in the 2-dose schedule for serotypes 5(87.2% versus 97.5% for the 3-dose primed subjects) and 6B(81.1% versus 90.3%),all other responses were comparable.
Nakon dodatne doze zamijećen je niži postotak cijepljenih s OPA titrima 8 u ispitanika cijepljenih s dvije doze, i to za serotip 5(87,2% nasuprot 97,5% za raspored cijepljenja s 3 doze) i 6B(81,1% nasuprot 90,3%), doksu svi ostali odgovori bili usporedivi.
Demographics were comparable between the sunitinib and placebo groups.
Demografska obilježja bila su slična u skupinama koje su primale sunitinib odnosno placebo.
The observed improvements in HbA1c andthe safety profiles were comparable between all age groups.
Opažena poboljšanja HbA1c isigurnosni profili bili su usporedivi između svih dobnih skupina.
The 2 treatment groups were comparable with respect to demographic and baseline disease characteristics.
Obje skupine bolesnika su bile usporedive s obzirom na demografske i početne karakteristike bolesti.
Furthermore, response rates in patients that completed the bedaquiline treatment period were comparable between different race categories in the clinical trials.
Nadalje, stope odgovora u kliničkim ispitivanjima u bolesnika koji su završili liječenje bedakilinom bile su usporedive između različitih rasa.
Gimeracil and uracil AUC0-12 values were comparable between the two groups, suggesting that DPD inhibition was similar for the Asian and Caucasian groups.
Vrijednosti AUC0-12 gimeracila i uracila bile su usporedive među skupinama pokazujući da je DPD inhibicija slična za grupu Azijata i bijelaca.
In the osteoporosis trials(PFT, HORIZON- Recurrent Fracture Trial[RFT])the pooled atrial fibrillation incidences were comparable between Aclasta(2.6%) and placebo 2.1.
U ispitivanjima osteoporoze(PFT, HORIZON- Recurrent Fracture Trial[RFT])objedinjene incidencije fibrilacije atrija bile su usporedive kod Aclaste(2,6%) i placeba 2, 1.
The safety and efficacy of RotaTeq were comparable between this subset of infants and infants born at term.
Sigurnost i djelotvornost RotaTeq cjepiva bila je usporediva između te skupine dojenčadi i dojenčadi rođene u terminu.
The frequency of serious adverse reactions anddiscontinuations due to adverse reactions in subjects with compensated cirrhosis were comparable to those seen in subjects without cirrhosis.
Učestalost ozbiljnih nuspojava iprekida liječenja zbog nuspojava u ispitanika s kompenziranom cirozom bila je usporediva s onom opaženom u ispitanika bez ciroze.
Pharmacokinetic parameters of simeprevir were comparable between patients with HCV genotype 1 infection with or without HIV-1 co-infection.
Farmakokinetički parametri simeprevira bili su usporedivi među bolesnicima s HCV infekcijom genotipom 1 sa ili bez HIV-1 koinfekcije.
Mean estimates for systemic clearance(0.28 mL/h/kg), volume of distribution(0.11 L/kg),and terminal half-life(14.3 days) were comparable between subcutaneous and intravenous administration.
Procijenjene prosječne vrijednosti sustavnog klirensa(0, 28 ml/h/kg), volumena distribucije(0, 11 l/kg) iterminalnog poluvijeka(14, 3 dana) bile su usporedive kod supkutane i intravenske primjene.
Results: 136, Time: 0.0422

Word-for-word translation

Top dictionary queries

English - Croatian